Literature DB >> 34019440

Interdisciplinary Approach to Thrombosis Management in COVID-19 at a Large Academic Center.

Manila Gaddh1, Cheryl L Maier2.   

Abstract

There is an increasing recognition of association of COVID-19 with a distinct coagulopathy and increased risk of thrombosis. Unfortunately, effective strategies to prevent and treat thrombosis in this patient population remain uncertain. In the setting of a worsening pandemic, there is an urgent need to provide practical guidance to the clinicians on management of the coagulopathy, while waiting for the results from large systematic trials to establish best practices. At our institution, we convened an interdisciplinary group of 25 experts in the field of thrombosis from different medical specialties to review available literature and brainstorm management strategies. The group provided a 3-tiered anticoagulation algorithm for patients with COVID-19 along with a pathway for multidisciplinary review of difficult or refractory cases, which are described in this manuscript. In these unprecedented times where medical decision making is made difficult by both the novelty of the disease and paucity of robust data, clinical algorithms such as the one presented here may prove to be helpful for frontline providers caring for individual patients.

Entities:  

Mesh:

Year:  2021        PMID: 34019440      PMCID: PMC8457792          DOI: 10.1200/OP.20.01056

Source DB:  PubMed          Journal:  JCO Oncol Pract        ISSN: 2688-1527


  25 in total

1.  Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System.

Authors:  Seda Bilaloglu; Yin Aphinyanaphongs; Simon Jones; Eduardo Iturrate; Judith Hochman; Jeffrey S Berger
Journal:  JAMA       Date:  2020-08-25       Impact factor: 56.272

2.  Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data.

Authors:  N Levitan; A Dowlati; S C Remick; H I Tahsildar; L D Sivinski; R Beyth; A A Rimm
Journal:  Medicine (Baltimore)       Date:  1999-09       Impact factor: 1.889

3.  Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.

Authors:  Maximilian Ackermann; Stijn E Verleden; Mark Kuehnel; Axel Haverich; Tobias Welte; Florian Laenger; Arno Vanstapel; Christopher Werlein; Helge Stark; Alexandar Tzankov; William W Li; Vincent W Li; Steven J Mentzer; Danny Jonigk
Journal:  N Engl J Med       Date:  2020-05-21       Impact factor: 91.245

Review 4.  COVID-19 is, in the end, an endothelial disease.

Authors:  Peter Libby; Thomas Lüscher
Journal:  Eur Heart J       Date:  2020-09-01       Impact factor: 29.983

5.  Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study.

Authors:  George Goshua; Alexander B Pine; Matthew L Meizlish; C-Hong Chang; Hanming Zhang; Parveen Bahel; Audrey Baluha; Noffar Bar; Robert D Bona; Adrienne J Burns; Charles S Dela Cruz; Anne Dumont; Stephanie Halene; John Hwa; Jonathan Koff; Hope Menninger; Natalia Neparidze; Christina Price; Jonathan M Siner; Christopher Tormey; Henry M Rinder; Hyung J Chun; Alfred I Lee
Journal:  Lancet Haematol       Date:  2020-06-30       Impact factor: 18.959

6.  Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19.

Authors:  Ishan Paranjpe; Valentin Fuster; Anuradha Lala; Adam J Russak; Benjamin S Glicksberg; Matthew A Levin; Alexander W Charney; Jagat Narula; Zahi A Fayad; Emilia Bagiella; Shan Zhao; Girish N Nadkarni
Journal:  J Am Coll Cardiol       Date:  2020-05-06       Impact factor: 24.094

7.  Fibrinolysis Shutdown and Thrombosis in a COVID-19 ICU.

Authors:  Christina Creel-Bulos; Sara C Auld; Mark Caridi-Scheible; Nicholas A Barker; Sarah Friend; Manila Gaddh; Christine L Kempton; Cheryl L Maier; Fadi Nahab; Roman Sniecinski
Journal:  Shock       Date:  2021-03-01       Impact factor: 3.454

8.  Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome.

Authors:  Elizabeth A Middleton; Xue-Yan He; Frederik Denorme; Robert A Campbell; David Ng; Steven P Salvatore; Maria Mostyka; Amelia Baxter-Stoltzfus; Alain C Borczuk; Massimo Loda; Mark J Cody; Bhanu Kanth Manne; Irina Portier; Estelle S Harris; Aaron C Petrey; Ellen J Beswick; Aleah F Caulin; Anthony Iovino; Lisa M Abegglen; Andrew S Weyrich; Matthew T Rondina; Mikala Egeblad; Joshua D Schiffman; Christian Con Yost
Journal:  Blood       Date:  2020-09-03       Impact factor: 25.476

9.  American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19.

Authors:  Adam Cuker; Eric K Tseng; Robby Nieuwlaat; Pantep Angchaisuksiri; Clifton Blair; Kathryn Dane; Jennifer Davila; Maria T DeSancho; David Diuguid; Daniel O Griffin; Susan R Kahn; Frederikus A Klok; Alfred Ian Lee; Ignacio Neumann; Ashok Pai; Menaka Pai; Marc Righini; Kristen M Sanfilippo; Deborah Siegal; Mike Skara; Kamshad Touri; Elie A Akl; Imad Bou Akl; Mary Boulos; Romina Brignardello-Petersen; Rana Charide; Matthew Chan; Karin Dearness; Andrea J Darzi; Philipp Kolb; Luis E Colunga-Lozano; Razan Mansour; Gian Paolo Morgano; Rami Z Morsi; Atefeh Noori; Thomas Piggott; Yuan Qiu; Yetiani Roldan; Finn Schünemann; Adrienne Stevens; Karla Solo; Matthew Ventresca; Wojtek Wiercioch; Reem A Mustafa; Holger J Schünemann
Journal:  Blood Adv       Date:  2021-02-09

Review 10.  Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications.

Authors:  Joan T Merrill; Doruk Erkan; Jerald Winakur; Judith A James
Journal:  Nat Rev Rheumatol       Date:  2020-07-30       Impact factor: 20.543

View more
  2 in total

1.  Better Anticoagulated Than Not! Hypercoagulability in COVID-19.

Authors:  Dhauna P Karam
Journal:  JCO Oncol Pract       Date:  2021-06-16

2.  Implications of Evolving Guidelines for Coagulopathy and Thrombosis Management in COVID-19.

Authors:  Himanshu Joshi
Journal:  JCO Oncol Pract       Date:  2021-07-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.